Search

everythinglearnresearchcommunity

for

Search:↓

Hair loss in men may be caused by inflammation triggered by hormones, and treatments reducing inflammation could potentially promote hair growth.

Some people experience lasting sexual, psychological, and sleep problems after using finasteride or SSRI antidepressants, possibly due to similar underlying causes.

Hormones like testosterone and estrogen significantly affect hair growth and structure.

Estrogens generally inhibit hair growth and improve skin quality, but their exact effects on hair follicles are complex and not fully understood.

5α reductase inhibitors treat hair loss but may cause sexual side effects and risks.

Hair follicle culture helps develop new treatments for hair loss.

Over 50% of women over 50 experience hair loss, with minoxidil being the only proven effective treatment.

Vitamin C derivative reduces hair loss-related protein in cells.

Topical minoxidil improves hair loss in 80% of women with breast cancer undergoing endocrine therapy.

Advancements in hair biology include new treatments and tools for hair growth and alopecia.

Cancer treatments targeting specific cells and the immune system can cause skin, mouth, hair, and nail problems, affecting patients' quality of life and treatment adherence.

Eating less sugar, milk, and saturated fats and more vegetables and fish may help treat and prevent acne.

Male pattern hair loss could hint at androgens affecting COVID-19 severity.

Inflammation may be linked to hair loss, and targeting specific enzymes could help treat it.

Finasteride and minoxidil are effective for hair regrowth, while treatments for alopecia areata have varying success and continuous treatment is necessary.

Certain medications including flutamide, spironolactone, and others effectively reduce excessive hair growth in women, especially when combined with lifestyle changes.

Endocrine therapies for cancer significantly increase the risk of hair loss.

No consistent link between genotype and phenotype in 5-α-Reductase type 2 deficiency.

Early diagnosis and treatment are crucial for preventing permanent hair loss in various scalp conditions, and while new treatments are promising, more research is needed to evaluate their effectiveness.

Spironolactone might help protect against severe lung problems in COVID-19 patients.

Menopause affects hair and skin; more research needed for treatment.

Dihydrotestosterone (DHT) doesn't affect rat skin cell growth, but it does change cell cycle, protein levels, and other cell functions, potentially shortening hair growth cycle.

Alternative treatments show promise for hair growth beyond traditional methods.

New treatments for skin diseases are more effective and patient-friendly, but many still lack a cure.

Dexamethasone affects hair growth by altering levels of proteins that either promote or inhibit hair follicle growth.

Epithelial-mesenchymal interactions control hair growth cycles through specific molecular signals.

Finasteride may cause long-lasting sexual side effects.

Prolactin affects hair growth and skin conditions, and could be a target for new skin disease treatments.

Menopause reduces skin collagen and elasticity, and while estrogen therapy can help, its risks require careful consideration.

S5αR inhibitors might help treat schizophrenia and other mental disorders but need more research.